IFNA1 and familial pancreatic carcinoma: This study together with our previous report showing a characteristically high sensitivity of pancreatic cancer cells to the direct cytotoxicity of IFN-α transgene expression (Hatanaka et al, 2004) suggests that IFN-α gene therapy is a promising therapeutic strategy for pancreatic cancer, due to its dual mechanisms of antitumour activities.